English  |  正體中文  |  简体中文  |  总笔数 :2826152  
造访人次 :  31816783    在线人数 :  1044
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"pei jer chen"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 501-525 / 883 (共36页)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-07-03T03:34:16Z Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice Lin W.-H.; Yeh S.-H.; Yang W.-J.; Yeh K.-H.; Fujiwara T.; Nii A.; Chang S.S.-C.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:16Z Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:15Z Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan Lee J.-T.; Shao P.-L.; Chang L.-Y.; Xia N.-S.; PEI-JER CHEN; Lu C.-Y.; Huang L.-M.
臺大學術典藏 2021-07-03T03:34:15Z Polymerase chain reaction with phase change as intrinsic thermal control Hsieh Y.-F.; Yonezawa E.; Kuo L.-S.; Yeh S.-H.; PEI-JER CHEN; Chen P.-H.
臺大學術典藏 2021-07-03T03:34:15Z Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:15Z Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C Su T.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; PEI-JER CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:14Z ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers Liu W.-H.; Chen C.-H.; Yeh K.-H.; Li C.-L.; Wu Y.-J.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:34:14Z Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel Cheng A.L.; Amarapurkar D.; Chao Y.; PEI-JER CHEN; Geschwind J.-F.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Park J.-W.
臺大學術典藏 2021-07-03T03:34:14Z Reduction of HBV replication prolongs the early immunological response to IFNα therapy Tan A.T.; Hoang L.T.; Chin D.; Rasmussen E.; Lopatin U.; Hart S.; Bitter H.; Chu T.; Gruenbaum L.; Ravindran P.; Zhong H.; Gane E.; Lim S.G.; Chow W.C.; PEI-JER CHEN; Petric R.; Bertoletti A.; Hibberd M.L.
臺大學術典藏 2021-07-03T03:34:14Z Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:13Z SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏 2021-07-03T03:34:13Z Eltrombopag increases platelet numbers in thrombocytopenic patients with hcv infection and cirrhosis, allowing for effective antiviral therapy Afdhal N.H.; Dusheiko G.M.; Giannini E.G.; PEI-JER CHEN; Han K.-H.; Mohsin A.; Rodriguez-Torres M.; Rugina S.; Bakulin I.; Lawitz E.; Shiffman M.L.; Tayyab G.-U.-N.; Poordad F.; Kamel Y.M.; Brainsky A.; Geib J.; Vasey S.Y.; Patwardhan R.; Campbell F.M.; Theodore D.
臺大學術典藏 2021-07-03T03:34:12Z Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection Liu C.-J.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:12Z Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma Tai W.-T.; Shiau C.-W.; PEI-JER CHEN; Chu P.-Y.; Huang H.-P.; Liu C.-Y.; Huang J.-W.; Chen K.-F.
臺大學術典藏 2021-07-03T03:34:12Z Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality Liu C.-J.; Chu Y.-T.; Shau W.-Y.; Kuo R.N.; PEI-JER CHEN; Lai M.-S.
臺大學術典藏 2021-07-03T03:34:11Z Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:11Z Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin Chen M.-Y.; Liu C.-H.; Chen T.-C.; Su T.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏 2021-07-03T03:34:11Z Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:10Z Reply Hsu C.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:10Z Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; Su T.-H.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-07-03T03:34:10Z Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:09Z Anti-viral treatment and cancer control Shih W.-L.; Fang C.-T.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:09Z Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy Huang Y.-W.; Hsu C.-K.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; PEI-JER CHEN; Hsu P.-N.; Yang S.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:09Z Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan Chen C.-L.; Yang W.-S.; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; Liu C.-J.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.; Chen C.-J.
臺大學術典藏 2021-07-03T03:34:09Z Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications Wu H.-L.; Kao J.-H.; Chen T.-C.; Wu W.-H.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen D.-S.; PEI-JER CHEN; Liu C.-J.

显示项目 501-525 / 883 (共36页)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每页显示[10|25|50]项目